Works matching IS 08876924 AND DT 2008 AND VI 22 AND IP 11

Results: 26

The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia.

Published in:

2008

By:

Chapiro, E.;
Radford-Weiss, I.;
Bastard, C.;
Luquet, I.;
Lefebvre, C.;
Callet-Bauchu, E.;
Leroux, D.;
Talmant, P.;
Mozziconacci, M.-J.;
Mugneret, F.;
Struski, S.;
Raynaud, S.;
Andrieux, J.;
Barin, C.;
Jotterand, M.;
Mossafa, H.;
Ramond, S.;
Terré, C.;
Lippert, E.;
Berger, F.

Publication type:

Letter

Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia.

Published in:

2008

By:

Caocci, G.;
Atzeni, S.;
Orrù, N.;
Azzena, L.;
Martorana, L.;
Littera, R.;
Ledda, A.;
La Nasa, G.

Publication type:

Letter

Association of KIR2DS4 and its variant KIR1D with leukemia.

Published in:

2008

By:

Giebel, S.;
Nowak, I.;
Wojnar, J.;
Krawczyk-Kulis, M.;
Holowiecki, J.;
Kyrcz-Krzemien, S.;
Kusnierczyk, P.

Publication type:

Letter

Reply to: Association of KIR2DS4 and its variant KIR1D with leukemia.

Published in:

2008

By:

Verheyden, S.;
Demanet, C.

Publication type:

Letter

Reply to Verheyden and Demanet.

Published in:

2008

By:

Giebel, S.;
Nowak, I.;
Majorczyk, E.;
Kusnierczyk, P.

Publication type:

Letter

Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization.

Published in:

2008

By:

Berger, M. G.;
Berger, J.;
Richard, C.;
Jeanpierre, S.;
Nicolini, F. E.;
Tournilhac, O.;
Michallet, M.;
Satta, V. M.

Publication type:

Letter

Ex vivo priming of CD4 T cells converts immunological tolerance into effective antitumor immunity in a murine model of acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2008, v. 22, n. 11, p. 2070, doi. 10.1038/leu.2008.193

By:

Hegazy, A. N.;
Klein, C.

Publication type:

Article

Impact of comorbidity indexes on non-relapse mortality.

Published in:

2008

By:

Xhaard, A.;
Porcher, R.;
Chien, J. W.;
de Latour, R. P.;
Robin, M.;
Ribaud, P.;
Rocha, V.;
Devergie, A.;
Ferry, C.;
Martin, P. J.;
Socié, G.;
Socié, G

Publication type:

journal article

HOX expression patterns identify a common signature for favorable AML.

Published in:

2008

By:

Andreeff, M.;
Ruvolo, V.;
Gadgil, S.;
Zeng, C.;
Coombes, K.;
Chen, W.;
Kornblau, S.;
Barón, A. E.;
Drabkin, H. A.;
Barón, A E

Publication type:

journal article

Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization.

Published in:

2008

By:

Berger, M. G.;
Berger, J.;
Richard, C.;
Jeanpierre, S.;
Nicolini, F. E.;
Tournilhac, O.;
Michallet, M.;
Maguer-Satta, V.

Publication type:

Correction Notice

Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G<sub>1</sub> cell cycle arrest and apoptosis.

Published in:

Leukemia (08876924), 2008, v. 22, n. 11, p. 2091, doi. 10.1038/leu.2008.204

By:

Gu, L.;
Gao, J.;
Li, Q.;
Zhu, Y. P.;
Jia, C. S.;
Fu, R. Y.;
Chen, Y.;
Liao, Q. K.;
Ma, Z.

Publication type:

Article

Investigating human leukemogenesis: from cell lines to in vivo models of human leukemia.

Published in:

Leukemia (08876924), 2008, v. 22, n. 11, p. 2029, doi. 10.1038/leu.2008.206

By:

Kennedy, J. A.;
Barabé, F.

Publication type:

Article

Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance.

Published in:

2008

By:

McCubrey, J. A.;
Abrams, S. L.;
Ligresti, G.;
Misaghian, N.;
Wong, E. W. T.;
Steelman, L. S.;
Bäsecke, J.;
Troppmair, J.;
Libra, M.;
Nicoletti, F.;
Molton, S.;
McMahon, M.;
Evangelisti, C.;
Martelli, A. M.;
Bäsecke, J

Publication type:

journal article

Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2.

Published in:

Leukemia (08876924), 2008, v. 22, n. 11, p. 2097, doi. 10.1038/leu.2008.213

By:

Klier, M.;
Anastasov, N.;
Hermann, A.;
Meindl, T.;
Angermeier, D.;
Raffeld, M.;
Fend, F.;
Quintanilla-Martinez, L.

Publication type:

Article

Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia.

Published in:

2008

By:

Castro, J. E.;
Sandoval-Sus, J. D.;
Bole, J.;
Rassenti, L.;
Kipps, T. J.

Publication type:

journal article

Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis.

Published in:

Leukemia (08876924), 2008, v. 22, n. 11, p. 2054, doi. 10.1038/leu.2008.217

By:

Müller, I.;
Vaegler, M.;
Holzwarth, C.;
Tzaribatchev, N.;
Pfister, S. M.;
Schütt, B.;
Reize, P.;
Greil, J.;
Handgretinger, R.;
Rudert, M.

Publication type:

Article

BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: some common and contrasting features.

Published in:

2008

By:

Cross, N. C. P.;
Daley, G. Q.;
Green, A. R.;
Hughes, T. P.;
Jamieson, C.;
Manley, P.;
Mughal, T.;
Perrotti, D.;
Radich, J.;
Skoda, R.;
Soverini, S.;
Vainchenker, W.;
Verstovsek, S.;
Villeval, J.-L.;
Goldman, J. M.

Publication type:

Editorial

Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation.

Published in:

Leukemia (08876924), 2008, v. 22, n. 11, p. 2020, doi. 10.1038/leu.2008.253

By:

Landolfi, R.;
Di Gennaro, L.;
Falanga, A.

Publication type:

Article

Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms.

Published in:

Leukemia (08876924), 2008, v. 22, n. 11, p. 1990, doi. 10.1038/leu.2008.280

By:

Kiladjian, J.-J.;
Chomienne, C.;
Fenaux, P.

Publication type:

Article

Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias.

Published in:

2008

By:

Gotlib, J.;
Cools, J.

Publication type:

journal article

Miscreant myeloproliferative disorder stem cells.

Published in:

Leukemia (08876924), 2008, v. 22, n. 11, p. 2011, doi. 10.1038/leu.2008.290

By:

Jamieson, C. H. M.;
Barroga, C. F.;
Vainchenker, W. P.

Publication type:

Article

STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-cell lymphoma.

Published in:

2008

By:

Ritz, O.;
Guiter, C.;
Dorsch, K.;
Dusanter-Fourt, I.;
Wegener, S.;
Jouault, H.;
Gaulard, P.;
Castellano, F.;
Möller, P.;
Leroy, K.;
Möller, P

Publication type:

Letter

Amonafide L-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia.

Published in:

2008

By:

Burcu, M.;
O'Loughlin, K. L.;
Ford, L. A.;
Baer, M. R.

Publication type:

Letter

In-vivo detectable antibodies directed against the oncofetal antigen/immature laminin receptor can recognize and control myeloma cells—clinical implications.

Published in:

2008

By:

Siegel, S.;
Friedrichs, B.;
Budde, A.-K.;
Barsoum, A.;
Coggin, J.;
Tiemann, M.;
Kabelitz, D.;
Zeis, M.

Publication type:

Letter

The WHO 2008 classification of Ph-myeloproliferative disorders: statement of the Czech MPD Working Group.

Published in:

2008

By:

Schwarz, J.;
Penka, M.;
Indrák, K.;
Pospíšlova, D.;
Pytlík, R.;
Dulíček, P.;
Doubek, M.;
Křen, L.;
Campr, V.

Publication type:

Letter

Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors.

Published in:

2008

By:

Mazzi, B.;
Clerici, T. D.;
Zanussi, M.;
Lupo Stanghellini, M. T.;
Vago, L.;
Sironi, E.;
Peccatori, J.;
Bernardi, M.;
Carrera, P.;
Palini, A.;
Rossini, S.;
Bordignon, C.;
Bonini, C.;
Ferrari, M.;
Ciceri, F.;
Fleischhauer, K.

Publication type:

Letter